Literature DB >> 14695801

Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation.

Kenji Iwatsuki1, Toshihiro Akihisa, Harukuni Tokuda, Motohiko Ukiya, Manabu Oshikubo, Yumiko Kimura, Takeshi Asano, Atsushi Nomura, Hoyoku Nishino.   

Abstract

A new triterpene acid, lucidenic acid P (1a), and two new triterpene acid methyl esters, methyl lucidenates P (1b) and Q (2b), were isolated and characterized from the fruiting body of the fungus Ganoderma lucidum. Their structures were elucidated on the basis of spectroscopic methods. In addition, eight known triterpene acids, lucidenic acids A (3a), C (4a), D(2) (5a), E(2) (6a), and F (7a) and ganoderic acids E (9a), F (10a), and T-Q (11a), and six known triterpene acid methyl esters, methyl lucidenates A (3b), D(2) (5b), E(2) (6b), F (7b), and L (8b) and methyl ganoderate F (10b), were isolated and identified from the fungus. All of the triterpenoids, with the exception of 7a, were evaluated with respect to their inhibitory effects on the induction of Epstein-Barr virus early antigen (EBV-EA) by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells, which is known to be a primary screening test for antitumor promoters. All of the compounds tested showed potent inhibitory effects on EBV-EA induction (96-100% inhibition at 1 x 10(3) mol ratio/TPA).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695801     DOI: 10.1021/np0302293

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  10 in total

Review 1.  Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications.

Authors:  Elsayed A Elsayed; Hesham El Enshasy; Mohammad A M Wadaan; Ramlan Aziz
Journal:  Mediators Inflamm       Date:  2014-11-23       Impact factor: 4.711

Review 2.  Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update.

Authors:  Buddha Bahadur Basnet; Li Liu; Li Bao; Hongwei Liu
Journal:  Mycology       Date:  2017-05-24

3.  Nortriterpenoids from the Fruiting Bodies of the Mushroom Ganoderma resinaceum.

Authors:  Xian-Qiang Chen; Ling-Xiao Chen; Jing Zhao; Yu-Ping Tang; Shao-Ping Li
Journal:  Molecules       Date:  2017-06-28       Impact factor: 4.411

Review 4.  Naturally Occurring Terpenes: A Promising Class of Organic Molecules to Address Influenza Pandemics.

Authors:  Suhad A A Al-Salihi; Fabrizio Alberti
Journal:  Nat Prod Bioprospect       Date:  2021-05-03

Review 5.  Nutritional Profile and Health Benefits of Ganoderma lucidum "Lingzhi, Reishi, or Mannentake" as Functional Foods: Current Scenario and Future Perspectives.

Authors:  Aly Farag El Sheikha
Journal:  Foods       Date:  2022-04-01

6.  Comprehensive metabolomics analysis based on UPLC-Q/TOF-MSE and the anti-COPD effect of different parts of Celastrus orbiculatus Thunb.

Authors:  Na Yang; Han Wang; Hongqiang Lin; Junli Liu; Baisong Zhou; Xiaoling Chen; Cuizhu Wang; Jinping Liu; Pingya Li
Journal:  RSC Adv       Date:  2020-02-26       Impact factor: 4.036

Review 7.  Medicinal Fungi with Antiviral Effect.

Authors:  Yu Zhang; Guoying Zhang; Jianya Ling
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

8.  Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms.

Authors:  Jie Liu; Kuniyoshi Shimizu; Akinobu Tanaka; Wakako Shinobu; Koichiro Ohnuki; Takanori Nakamura; Ryuichiro Kondo
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

Review 9.  Antiviral Agents From Fungi: Diversity, Mechanisms and Potential Applications.

Authors:  Riikka Linnakoski; Dhanik Reshamwala; Pyry Veteli; Marta Cortina-Escribano; Henri Vanhanen; Varpu Marjomäki
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

10.  Quercetin Synergistically Inhibit EBV-Associated Gastric Carcinoma with Ganoderma lucidum Extracts.

Authors:  Sora Huh; Seulki Lee; Su Jin Choi; Zhexue Wu; Jae-Han Cho; Lina Kim; Yu Su Shin; Byung Woog Kang; Jong Gwang Kim; Kwanghyeon Liu; Hyosun Cho; Hyojeung Kang
Journal:  Molecules       Date:  2019-10-24       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.